Latest filing published 18 Mar 2016 for Enzo Biochem INC, €11k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Bernard L. Kasten: trading record in brief
This profile gathers the share dealings of Bernard L. Kasten across 4 companies, led by Enzo Biochem Inc, Cytocom, Inc. and Genelink Inc. In total, 34 filings cover trades dated from 21 September 2006 to 11 March 2016.
The open-market side counts 7 purchases for €90k alongside 11 sales for €218k. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants and 2 option exercises. In 2016 alone, the filings show no purchases and 6 sales.
In size, the median ticket on the buying side is €9,002.
Most recently, on 18 March 2016, the filings show an open-market sale worth €11k in Enzo Biochem Inc. The latest purchase dates back some time: it was published 5,564 days ago, on 15 August 2011. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bernard L. Kasten
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$4.666.9% of flowCommon StockSEC:0000914760-16-000389:0
- 1,857 shares@ US$4.404.8% of flowCommon StockSEC:0000914760-16-000389:1
- 9,720 shares@ US$4.4025.0% of flowCommon StockSEC:0000914760-16-000389:2
- 18,651 shares@ US$3.4737.9% of flowCommon StockSEC:0000914760-16-000389:3
- 3,100 shares@ US$4.397.8% of flowCommon StockSEC:0000914760-16-000389:4
- 6,954 shares@ US$4.4117.6% of flowCommon StockSEC:0000914760-16-000389:5
- 3,067 shares@ US$4.91Common Stock, par value $0.01SEC:0000914760-14-000119:0
- 333 shares@ US$4.91Common Stock, par value $0.01SEC:0000914760-14-000119:1
- 5,000 shares@ US$4.95Common Stock, par value $0.01SEC:0000914760-14-000119:2
- 5,000 shares@ US$4.94Common Stock, par value $0.01SEC:0000914760-14-000119:3
- 2,500 shares@ US$4.93Common Stock, par value $0.01SEC:0000914760-14-000119:4
- 3,200 shares@ US$4.95Common Stock, par value $0.01SEC:0000930413-14-003282:0
- 12,498 shares@ US$5.01Common Stock, par value $0.01SEC:0000930413-14-003282:1
- 7,500 shares@ US$4.17Common Stock, par value $0.01SEC:0000930413-14-001798:0
- 2,500 shares@ US$3.99Common Stock, par value $0.01SEC:0000930413-14-001591:0
- 5,000 shares@ US$4.39Common Stock, par value $0.01SEC:0000930413-14-001591:1
- 6,342 shares0Common stock, par value $0.005 per shareSEC:0001171843-12-002425:0
- 5,000 shares@ US$2.58Common Stock, par value $0.005 per shareSEC:0001144204-11-047124:0Canonical exit: 13 Nov 2011 (T+90)
- 5,000 shares@ US$2.60Common Stock, par value $0.005 per shareSEC:0001144204-11-047124:1Canonical exit: 13 Nov 2011 (T+90)
- 500,000 shares@ US$0.05Common StockSEC:0001144204-11-029586:0
- 1,000,000 shares@ US$0.05Common StockSEC:0001144204-11-002177:0
- 2,000 shares@ US$6.10Common Stock, par value $0.005 per shareSEC:0001144204-10-062975:0Canonical exit: 16 Feb 2011 (T+90)
- 10,000 shares@ US$6.15Common Stock, par value $0.005 per shareSEC:0001144204-10-062975:1Canonical exit: 17 Feb 2011 (T+90)
- 1,562,500 shares@ US$0.08common stockSEC:0001209191-10-037988:0
- 8,389 shares0Common StockSEC:0001144204-10-032873:0
25 of 32 declarations
